Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Preclinical study characterizes the binding affinity and selectivity of a selective FLT3 inhibitor

Preclinical study characterizes the binding affinity and selectivity of a selective FLT3 inhibitor

New 'Immuno-Engineering to Improve Immunotherapy' Center formed to advance cancer therapy

New 'Immuno-Engineering to Improve Immunotherapy' Center formed to advance cancer therapy

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

Breakthrough discovery could open up new treatments for some blood cancers

Breakthrough discovery could open up new treatments for some blood cancers

Smoking cessation goody bag helps people quit smoking

Smoking cessation goody bag helps people quit smoking

New research could lead to 'breakthrough' for myelodysplastic syndrome

New research could lead to 'breakthrough' for myelodysplastic syndrome

Inexpensive drug may be used to counteract treatment resistance in patients with leukemia

Inexpensive drug may be used to counteract treatment resistance in patients with leukemia

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

Biomaterial-based vaccine has potential to completely eliminate AML cells

Biomaterial-based vaccine has potential to completely eliminate AML cells

Leukemic cells are addicted to vitamin B6, research shows

Leukemic cells are addicted to vitamin B6, research shows

Researchers move closer to identifying leukemic stem cells

Researchers move closer to identifying leukemic stem cells

Artificial intelligence can detect AML with high reliability

Artificial intelligence can detect AML with high reliability

Yale researchers identify cellular chicanery that jumpstarts cancer

Yale researchers identify cellular chicanery that jumpstarts cancer

Leukemia patients treated with common cancer drug have heightened risk of heart failure

Leukemia patients treated with common cancer drug have heightened risk of heart failure

New therapy shows dramatic effect against worst types of leukaemias

New therapy shows dramatic effect against worst types of leukaemias

Study provides most detailed classification of acute myeloid leukemia, myelodysplastic syndrome

Study provides most detailed classification of acute myeloid leukemia, myelodysplastic syndrome

Researchers aim to exploit DNA mutations in the treatment of blood and bone marrow cancers

Researchers aim to exploit DNA mutations in the treatment of blood and bone marrow cancers

Transplant patient finds out his DNA has been replaced by that of his donor

Transplant patient finds out his DNA has been replaced by that of his donor

Rutgers researchers identify small mutations for AML and MDS through deep DNA sequencing

Rutgers researchers identify small mutations for AML and MDS through deep DNA sequencing

Pairing chemotherapy azacitidine with enasidenib boosts complete remission in AML patients

Pairing chemotherapy azacitidine with enasidenib boosts complete remission in AML patients